RESTYLANE INJECTABLE GEL
FDA premarket approval P040024/S050 · decided 2011-07-01
Approval details
- PMA number
- P040024
- Supplement
- S050
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- RESTYLANE INJECTABLE GEL
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2010-10-22
- Decision date
- 2011-07-01
- Days to decision
- 252 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- APPROVAL FOR A CHANGE IN THE COMPOSITION OF THE BIOLOGICAL INDICATOR USED FOR QUALIFICATION AND REQUALIFICATION OF THE STEAM STERILIZATION PROCEDURE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.